Mali vs Small island developing States (SIDS): Percentage of bloodstream infection due to Escherichia coli resistant
Mali
60.9%
in 2022
Small island developing States (SIDS)
50.0%
in 2022
Mali rank
10th
Small island developing States (SIDS) rank
8th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Mali
- Small island developing States (SIDS)
How they compare
Mali currently reports 60.9% against 50.0% in Small island developing States (SIDS), a difference of 10.9%.
That makes Mali's figure about 1.2 times Small island developing States (SIDS)'s.
The two have swapped places 1 time across 5 shared years of data; in 2018 it was Small island developing States (SIDS) ahead.
Mali ranks 10th and Small island developing States (SIDS) ranks 8th of 50 countries.
Across the 2 decades both report, Mali averaged higher in 1 and Small island developing States (SIDS) in 1.
Head to head by decade
| Decade | Mali | Small island developing States (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 35.9% | 45.9% | 10.0% | Small island developing States (SIDS) |
| 2020s | 56.0% | 43.4% | 12.6% | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Mali or Small island developing States (SIDS)?
- Mali, at 60.9% against 50.0% in Small island developing States (SIDS) as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Mali and Small island developing States (SIDS)?
- 10.9%, with Mali ahead.
- How many years of comparable data are there for Mali and Small island developing States (SIDS)?
- 5 years are reported by both, from 2018 to 2022.
- How do Mali and Small island developing States (SIDS) rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Mali ranks 10th and Small island developing States (SIDS) ranks 8th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.